PFO
Pathstone Family Office Portfolio holdings
AUM
$12.8B
1-Year Return
21.1%
This Quarter Return
-3.46%
1 Year Return
+21.1%
3 Year Return
+39.33%
5 Year Return
+59.76%
10 Year Return
+223.2%
AUM
$12.8B
AUM Growth
+$5.82B
(+83%)
Cap. Flow
+$6.29B
Cap. Flow
% of AUM
48.92%
Top 10 Holdings %
Top 10 Hldgs %
38.41%
Holding
1,696
New
460
Increased
1,031
Reduced
106
Closed
40
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$730M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$535M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$465M |
| 4 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$439M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
$297M |
Top Sells
Sector Composition
| 1 | Technology | 12.88% |
| 2 | Financials | 6.23% |
| 3 | Consumer Discretionary | 5.34% |
| 4 | Consumer Staples | 4.14% |
| 5 | Healthcare | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Personalis
PSNL
$451M
| $44.9K | ﹤0.01% |
37,081
+22,204
| +149% | +$26.9K |
|
1627
Quantum-Si Incorporated
QSI
$217M
| $43.2K | ﹤0.01% |
+26,039
| New | +$43.2K |
|
|
FAX
1628
abrdn Asia-Pacific Income Fund
FAX
$675M
| $41.5K | ﹤0.01% |
2,824
+624
| +28% | +$9.17K |
|
1629
Forian
FORA
$66.9M
| $39.3K | ﹤0.01% |
17,640
| – | – |
|
1630
fuboTV
FUBO
$1.29B
| $37.9K | ﹤0.01% |
14,185
+4,185
| +42% | +$11.2K |
|
|
CMU
1631
MFS High Yield Municipal Trust
CMU
$84.4M
| $37.2K | ﹤0.01% |
+11,881
| New | +$37.2K |
|
1632
Wheels Up
UP
$1.73B
| $36.7K | ﹤0.01% |
+17,711
| New | +$36.7K |
|
|
SRTA
1633
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$341M
| $36.3K | ﹤0.01% |
+14,032
| New | +$36.3K |
|
1634
Lumen
LUMN
$5.1B
| $35K | ﹤0.01% |
24,303
-21,978
| -47% | -$31.6K |
|
|
NSTG
1635
DELISTED
NanoString Technologies, Inc.
NSTG
| $33.1K | ﹤0.01% |
+19,243
| New | +$33.1K |
|
1636
Blink Charging
BLNK
$117M
| $32.2K | ﹤0.01% |
+10,516
| New | +$32.2K |
|
1637
Pagaya Technologies
PGY
$2.85B
| $31.9K | ﹤0.01% |
+1,683
| New | +$31.9K |
|
1638
Denison Mines
DNN
$2.04B
| $31.8K | ﹤0.01% |
19,300
| – | – |
|
1639
Cerus
CERS
$255M
| $29.9K | ﹤0.01% |
18,450
+1,000
| +6% | +$1.62K |
|
1640
Geron
GERN
$880M
| $25.9K | ﹤0.01% |
+12,200
| New | +$25.9K |
|
|
VZLA
1641
Vizsla Silver
VZLA
$1.25B
| $22.4K | ﹤0.01% |
21,644
+10,000
| +86% | +$10.4K |
|
1642
Clover Health Investments
CLOV
$1.38B
| $22.3K | ﹤0.01% |
20,683
| – | – |
|
1643
Talkspace
TALK
$440M
| $20.4K | ﹤0.01% |
10,476
| – | – |
|
1644
Arbutus Biopharma
ABUS
$769M
| $20.3K | ﹤0.01% |
10,000
| – | – |
|
1645
Vicarious Surgical
RBOT
$34M
| $20.2K | ﹤0.01% |
1,141
-34
| -3% | -$603 |
|
1646
Rigetti Computing
RGTI
$4.9B
| $18K | ﹤0.01% |
+13,500
| New | +$18K |
|
1647
Eledon Pharmaceuticals
ELDN
$156M
| $17.9K | ﹤0.01% |
+13,029
| New | +$17.9K |
|
|
KRON
1648
DELISTED
Kronos Bio
KRON
| $15.6K | ﹤0.01% |
12,034
| – | – |
|
1649
X4 Pharmaceuticals
XFOR
$81.7M
| $13.8K | ﹤0.01% |
+421
| New | +$13.8K |
|
1650
Clene
CLNN
$59.4M
| $12.5K | ﹤0.01% |
+1,262
| New | +$12.5K |
|